BR Biopharma, Inc. (NASDAQ:BRBI) Plans Quarterly Dividend of $0.14

BR Biopharma, Inc. (NASDAQ:BRBIGet Free Report) announced a quarterly dividend on Friday, August 7th. Shareholders of record on Monday, August 17th will be paid a dividend of 0.1415 per share on Friday, September 4th. This represents a c) annualized dividend and a yield of 6.0%. The ex-dividend date of this dividend is Monday, August 17th.

BR Biopharma Trading Up 0.5%

BRBI stock opened at $9.40 on Friday. BR Biopharma has a fifty-two week low of $9.23 and a fifty-two week high of $67.01. The stock’s 50 day moving average price is $11.32.

BR Biopharma (NASDAQ:BRBIGet Free Report) last issued its quarterly earnings results on Tuesday, June 30th. The company reported $0.09 EPS for the quarter. The company had revenue of $25.13 million during the quarter.

About BR Biopharma

(Get Free Report)

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.

Further Reading

Receive News & Ratings for BR Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BR Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.